Login / Signup

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.

Marion SubkleweAndreas BurchertGloria IacoboniPierre SesquesLars FranseckyVeit L BückleinCorinna TrenkerRafael HernaniRalph NaumannJonas A SchäferViktoria BlumenbergChristian SchmidtKristina SohlbachMichael von Bergwelt-BaildonEmmanuel BachyPere Barba
Published in: Blood advances (2022)
Keyphrases
  • cell therapy
  • stem cells
  • early onset
  • mesenchymal stem cells
  • nk cells
  • bone marrow